We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$31.9B
AUM Growth
+$2.38B
Cap. Flow
+$1.7B
Cap. Flow %
5.32%
Top 10 Hldgs %
15.42%
Holding
3,195
New
265
Increased
1,619
Reduced
1,032
Closed
182

Sector Composition

Rank Sector Weight
1 Healthcare 9.59%
2 Technology 8.36%
3 Consumer Staples 8.04%
4 Financials 7.78%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WATT icon
2676
Energous
WATT
$102M
$182K ﹤0.01%
+23
New +$150K
ILG
2677
DELISTED
ILG, Inc Common Stock
ILG
$182K ﹤0.01%
+11,460
New +$164K
SCMP
2678
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$182K ﹤0.01%
16,603
+1,781
+12% +$19.9K
ASG
2679
Liberty All-Star Growth Fund
ASG
$341M
$181K ﹤0.01%
44,254
-910
-2% -$3.71K
VKI icon
2680
Invesco Advantage Municipal Income Trust II
VKI
$401M
$181K ﹤0.01%
+13,569
New +$174K
DBU
2681
DELISTED
WISDOMTREE GLOBAL EX-US UTILITY FND (DE)
DBU
$180K ﹤0.01%
+11,258
New +$179K
RGP icon
2682
Resources Connection
RGP
$145M
$179K ﹤0.01%
+12,138
New +$180K
BGX
2683
Blackstone Long-Short Credit Income Fund
BGX
$138M
$177K ﹤0.01%
12,252
+42
+0.3% +$595
KND
2684
DELISTED
Kindred Healthcare
KND
$177K ﹤0.01%
15,721
-1,466
-9% -$18.4K
SAH icon
2685
Sonic Automotive
SAH
$2.61B
$174K ﹤0.01%
10,152
-2,347
-19% -$40.6K
TROX icon
2686
Tronox
TROX
$1.04B
$174K ﹤0.01%
39,494
+3,024
+8% +$17.2K
NVIV
2687
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$174K ﹤0.01%
2
+1
+100% +$118K
CB icon
2688
CALL
Chubb
CB
$135B
$173K ﹤0.01%
29,900
+8,200
+38% +$1.01M
LUMO
2689
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$173K ﹤0.01%
1,702
-289
-15% -$35.8K
AKBA icon
2690
Akebia Therapeutics
AKBA
$252M
$172K ﹤0.01%
22,937
-228
-1% -$1.99K
FT
2691
Franklin Universal Trust
FT
$197M
$172K ﹤0.01%
24,978
+333
+1% +$2.17K
HERZ
2692
Herzfeld Credit Income Fund
HERZ
$31.6M
$168K ﹤0.01%
3,550
+915
+35% +$46.2K
CDR
2693
DELISTED
Cedar Realty Trust, Inc
CDR
$168K ﹤0.01%
3,428
-479
-12% -$22.2K
PCN
2694
PIMCO Corporate & Income Strategy Fund
PCN
$885M
$167K ﹤0.01%
10,856
-367
-3% -$5.34K
BGT icon
2695
BlackRock Floating Rate Income Trust
BGT
$325M
$166K ﹤0.01%
12,788
+110
+0.9% +$1.42K
SWZ
2696
Swiss Helvetia Fund
SWZ
$77.5M
$165K ﹤0.01%
15,976
+1,000
+7% +$10.3K
SIEN
2697
DELISTED
Sientra, Inc.
SIEN
$165K ﹤0.01%
2,500
NPF
2698
DELISTED
NUVEEN PREMIER MUNI INCOME FD
NPF
$165K ﹤0.01%
10,926
-1,510
-12% -$22.2K
BATRA icon
2699
Atlanta Braves Holdings Series A
BATRA
$3.43B
$163K ﹤0.01%
+10,833
New +$167K
CPAC
2700
Cementos Pacasmayo
CPAC
$1.01B
$163K ﹤0.01%
+14,638
New +$160K

Similar funds

Raymond James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Raymond James & Associates held 3,195 positions worth $31.9B, up 8.1% from $29.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.7B of net new capital in Q2 2016, opening 265 new positions and adding to 1,619 existing holdings. Its largest new stake was Schwab US REIT ETF: 467,710 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 9% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Europe Hedged Equity Fund, an estimated $43.1M trimmed.

  • Raymond James & Associates's largest Q2 2016 buy was Schwab US REIT ETF: 467,710 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $107M increase.
  • Raymond James & Associates's biggest Q2 2016 reduction was WisdomTree Europe Hedged Equity Fund, cutting an estimated $43.1M.
  • Raymond James & Associates fully exited ADT Corp in Q2 2016, selling an estimated $34.4M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $31.9B portfolio in Q2 2016.
  • Raymond James & Associates opened 265 new positions and closed 182 in Q2 2016.
  • Raymond James & Associates's portfolio value rose 8.1% quarter-over-quarter to $31.9B.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.